Izimpawu Ezihlangene Zihlanganiswe Nezinkinga Zokugaya Amathumbu
I-arthritis ye-enteropathic yisimiso sokuvuvukala esithinta umgogodla nezinye izixhumanisi ezivame ukuvela ezifweni zesibindi ezivuvukalayo - isifo sikaCrohn nesifo sofuba esiswini. I-arthritis evuvukala ehlobene nezinye izifo ezingenayo i-enteropathic, ezifana nesifo se-celiac nesifo sika-Whipple, azijwayele ukufakwa "ku-arthritis ye-enteropathic".
I-arthritis ye-enteropathic ihlukaniswa njengenye ye- spondyloarthropathies . Amanye ama-spondyloarthropathies ahlanganisa i- spondylitis e-ankylosing , i- psoriatic arthritis , kanye nesifo samathambo esisebenzayo . "Ukungalingani" kubhekisela kunoma yisiphi isifo esihlobene namathumbu.
Ukuthuthukisa i-Arthritis ye-Enteropathic
I-arthritis ivela ngamaphesenti angaba ngu-20 abantu abanesifo sofuba esibhubhisayo, abanesifo esiphakeme phakathi kwalabo abanesifo sikaCrohn uma kuqhathaniswa nalabo abane-ulcerative colitis. Ku-arthritis ye-enteropathic, izimpawu ze-arthritis zingandulela izimpawu zamathumbu isikhathi eside.
Kuze kube yilapho izimpawu zomzimba zibonakala, i-arthritis ivame ukuhlukaniswa njenge-Spondyloarthritis engabonakali. Nokho, iningi labantu abane-arthritis e-enteropathic, seliye latholaka ukuthi linesifo sofuba esishubile.
Imiphumela yokufundwa eyanyatheliswa ku-Clinical Rheumatology iphakamise ukuthi i-IL-23, i-biomarker, iphakeme kubantu abanezifo zesifo sofuba, ikakhulukazi isifo sika-Crohn, futhi sikhulu kulabo abane-arthritis ye-peripheral kanye / noma ye-axial uma kuqhathaniswa nezilawuli.
Ucwaningo olwengeziwe luyadingeka, kodwa kungase kube ukutholwa okukhulu okungaholela ekuhlosweni okusha kokwelapha.
Izimpawu
I-arthritis ye-enteropathic ingase ivele njenge-axial arthritis, i-arthritis ye-périphher, noma ixutshwe. Njenge-arthritis ye-axial, izimpawu zobuhlungu be-back and stiffness zifana ne-ankylosing spondylitis futhi zingase zilandele izimpawu zesisu.
Njengomuthi we-arthritis, kukhona ngokuvamile iphethini lama-pauciarticular (amajoyine amane noma ambalwa afakiwe) kanye ne-arthritis e-asymmetric (amathinteli aphethwe yizona ezingekho ohlangothini olufanayo lomzimba). Izinkinga zamathumbu zingenzeka ngesikhathi esifanayo ne-arthritis noma i-arthritis ingenzeka ngaphambi kwesifo sofuba.
Ukuxilongwa
Ingxoxo evulekile futhi eqotho nodokotela wakho mayelana nazo zonke izimpawu zakho yindawo ozoqala ngayo. Odokotela ngokuvamile bahlola ukuhlola:
- i-anemia
- i- CRP ephakeme ne- ESR yokubonisa ukuvuvukala
- ukuntuleka kwezinguquko ezishintshayo kwi-x ray yezingxenye zomzimba
- i-sacroiliac ne-spine x-ray efana ne-ankylosing spondylitis
Ucwaningo olulodwa, olushicilelwe ekubuyekezweni okuzenzakalelayo, luhlolwe ukusebenza komtholampilo wezinsikazi kanye ne-Rheumatologic. Ucwaningo luveze ukuthi abantu abane-spondylitis babe nokusabalalisa okuphezulu kwamanye ukubonakaliswa kwamathambo okuzenzekelayo futhi bathola ukwelashwa okwengeziwe nge- block block ye-TNF kunabantu abanesifo sofuba esibhubhisayo.
Labo ababenesifo baqala ukuphuma kwe-spondylitis yokungena eminyakeni eyishumi phakathi kuka-1980 kuya ku-1990 no-1991 kuya ku-2001 babhekana nokubambezeleka okuphawulekayo ekuxilongweni. Kuye kwathuthuka kakhulu.
Abantu ababenesifo sokuqala kwesifo se-spondylitis phakathi kwe-2002 kuya ku-2012 bekuncishiswe ukubambezeleka ekuhloleni.
Kusobala ukuthi imitholampilo enezinqubo eziningi, ngokugxila kokubili izimpawu ezihlanganyelwe kanye nezimpawu zamathumbu, iyilungele lokhu kutholakala.
Ukwelapha
I-arthritis ye-enteropathic iphathwa ngokufana nezinye izimpikane ze-spondyloarthropathies zezimpawu ezihlangene. Inkinga ukuthi lezi zombili izimo kufanele zithathwe-i-arthritis kanye nesifo sofuba-kodwa njengoba ama-NSAID angaphatha kahle i-arthritis, izidakamizwa zingenza izifo zesisu zibe zibi nakakhulu.
I-TNF inhibitors, ehlanganisa Remicade (infliximab), i- Humira (adalimumab) ne- Cimzia (certolizumab pegol) isetshenziswe ngempumelelo ukuphatha isifo sofuba esiswini.
Zibuye zisebenze futhi nge-arthritis evuthayo.
Izwi elivela
Ngokusho kweSpondylitis Association of America, inkambo nobukhulu be-arthritis ye-enteropathic ziyahlukahluka komunye nomuntu. Ngenkathi izifo zesifo ku-arthritis ye-enteropathic zivame ukuzithiba futhi zenzeke ngemva kwamasonto ayisithupha, ukuphindaphinda kuvamile. Futhi, ingxenye ye-arthritis ye-arthritis ye-enteropathic ingase ibe yindlala futhi ingase ihlotshaniswe nokubhujiswa okuhlangene. Ayikho ikhambi elaziwa le-arthritis ye-enteropathic, kodwa imithi isiza ukulawula kokubili isilonda kanye nezici ze-arthritic ye-arthritis ye-enteropathic.
> Imithombo:
> Spondyloarthritis ye-Enteropathic. I-Primer kuma-Rheumatic Diseases. Umagazini weshumi nantathu. Ishicilelwe yi-Arthritis Foundation.
> Gheita, TA. Ukubandakanya i-IL-23 kumagciwane e-enteropathic arthritis abanezifo ezikhukhumeza izifo: imiphumela yokuqala. I-Rheumatology yezokwelapha. May Meyi 2014; 33 (5): 713-7.
> Conigliaro P., et al. Umthelela wendlela yokuzibandakanya kwamanye amazwe ezigulini ze-entopathic spondyloarthritis. Ukubuyekeza okuzenzakalelayo. 2016 Feb; 15 (2): 184-90.
> Sibutsetelo se-Enteropathic Arthritis / Arthritis Ehlanganiswa Nezifo Zengqondo Ezivuthayo. I-Spondylitis Association of America.